WOOD; Jill E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for WOOD; Jill E..The latest application filed is for "omega-carboxyarl substituted diphenyl ureas as raf kinase inhibitors".

Company Profile

0.15.41

WOOD; Jill E. - North Haven CT
WOOD; Jill E. - Hamden CT
Wood; Jill E. - Ft. Collins CO
Wood; Jill E. - Hamde CT
Wood; Jill E - Hamden CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Omega-carboxyarl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20140329866 - RIEDL; Bernd ; et al.	2014-11-06
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Grant 8,841,330 - Riedl , et al. September 23, 2	2014-09-23
Inhibition Of P38 Kinase Using Symmetrical And Unsymmetrical Diphenyl Ureas App 20120270878 - MILLER; Scott ; et al.	2012-10-25
Raf Kinase Inhibitors App 20120178780 - WOOD; Jill E. ; et al.	2012-07-12
Omega-carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20120142742 - Riedl; Bernd ; et al.	2012-06-07
Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas App 20120129893 - DUMAS; Jacques ; et al.	2012-05-24
.omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Grant 8,124,630 - Riedl , et al. February 28, 2	2012-02-28
Omega Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20120040986 - RIEDL; Bernd ; et al.	2012-02-16
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas Grant 7,928,239 - Dumas , et al. April 19, 2	2011-04-19
.omega.-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors Grant 7,897,623 - Riedl , et al. March 1, 2	2011-03-01
Raf Kinase Inhibitors App 20100063088 - WOOD; Jill E. ; et al.	2010-03-11
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas Grant 7,625,915 - Dumas , et al. December 1, 2	2009-12-01
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS App 20090118268 - Riedl; Bernd ; et al.	2009-05-07
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas Grant 7,517,880 - Miller , et al. April 14, 2	2009-04-14
Inhibition Of P38 Kinase Using Symmetrical And Unsymmetrical Diphenyl Ureas App 20090093526 - Miller; Scott ; et al.	2009-04-09
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas App 20080300281 - Dumas; Jacques ; et al.	2008-12-04
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas App 20080269265 - Miller; Scott ; et al.	2008-10-30
Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas App 20080194580 - Dumas; Jacques ; et al.	2008-08-14
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas Grant 7,371,763 - Dumas , et al. May 13, 2	2008-05-13
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20080108672 - Riedl; Bernd ; et al.	2008-05-08
.omega.-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Grant 7,351,834 - Riedl , et al. April 1, 2	2008-04-01
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas Grant 7,329,670 - Dumas , et al. February 12, 2	2008-02-12
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors App 20080032979 - Riedl; Bernd ; et al.	2008-02-07
omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors App 20080027061 - Riedl; Bernd ; et al.	2008-01-31
Inhibition Of Raf Kinase Using Aryl And Heteroaryl Substituted Heterocyclic Ureas App 20080009527 - Dumas; Jacques ; et al.	2008-01-10
Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas App 20070244120 - Dumas; Jacques ; et al.	2007-10-18
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Grant 7,235,576 - Riedl , et al. June 26, 2	2007-06-26
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 7,109,196 - Wang , et al. September 19, 2	2006-09-19
1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20060189609 - Wang; Yamin ; et al.	2006-08-24
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas App 20060019990 - Dumas; Jacques ; et al.	2006-01-26
Raf kinase inhibitors App 20050256174 - Wood, Jill E. ; et al.	2005-11-17
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 6,900,205 - Wang , et al. May 31, 2	2005-05-31
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040209866 - Wang, Yamin ; et al.	2004-10-21
17-beta-hydroxysteroid dehydrogenase-II inhibitors Grant 6,784,167 - Wood , et al. August 31, 2	2004-08-31
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas App 20040102636 - Miller, Scott ; et al.	2004-05-27
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040014751 - Wang, Yamin ; et al.	2004-01-22
Omega-carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20030207872 - Riedl, Bernd ; et al.	2003-11-06
Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas App 20030207914 - Dumas, Jacques ; et al.	2003-11-06
omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20030181442 - Riedl, Bernd ; et al.	2003-09-25
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20030144278 - Riedl, Bernd ; et al.	2003-07-31
Method and/or process for preparing omega-carboxyaryl substituted diphenyl ureas as raf kinas inhibitors App 20030139605 - Riedl, Bernd ; et al.	2003-07-24
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors App 20030105091 - Riedl, Bernd ; et al.	2003-06-05
17-Beta-hydroxysteroid dehydrogenase-II inhibitors App 20030087952 - Wood, Jill E. ; et al.	2003-05-08
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas App 20020165394 - Dumas, Jacques ; et al.	2002-11-07
Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20020137774 - Riedl, Bernd ; et al.	2002-09-26
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors App 20020065296 - Dumas, Jacques ; et al.	2002-05-30
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20020042517 - Uday, Khire ; et al.	2002-04-11
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20010034447 - Riedl, Bernd ; et al.	2001-10-25
Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitors App 20010027202 - Riedl, Bernd ; et al.	2001-10-04
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20010016659 - Riedl, Bernd ; et al.	2001-08-23
Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors App 20010011135 - Riedl, Bernd ; et al.	2001-08-02
omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitors App 20010011136 - Riedl, Bernd ; et al.	2001-08-02
Raf kinase inhibitors App 20010006975 - Wood, Jill E. ; et al.	2001-07-05
Inhibition of raf kinase activity using aryl ureas Grant 6,187,799 - Wood , et al. February 13, 2	2001-02-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.